NUAK2: A Key Regulator of Cell Proliferation and Survival

Comprehensive genomic and functional analysis of NUAK2 (SNARK) in health and disease

Gene Information Card

Symbol NUAK2
Full Name NUAK family kinase 2
Gene Type Protein coding
Chromosomal Location 1q32.1
NCBI Gene ID 81788 ncbi.nlm.nih.gov/gene/81788
Ensembl ID ENSG00000117676
UniProt ID Q9H093
OMIM ID 608131
HGNC ID 29558
Aliases SNARK, FLJ90358

Description

NUAK2 (NUAK family kinase 2), also known as SNARK, is a serine/threonine protein kinase belonging to the AMPK-related kinase family. It plays a critical role in regulating cell proliferation, survival, and metabolism. NUAK2 is involved in cellular stress responses and has been implicated in cancer progression, particularly through its effects on the Hippo signaling pathway and MYC stability.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hepatocellular carcinoma NUAK2 overexpression promotes cell proliferation and tumor growth via MYC stabilization and YAP activation. COSMIC; PMID: 29281825
Breast cancer NUAK2 amplification and overexpression correlate with poor prognosis and resistance to therapy. COSMIC; PMID: 25605248
Colorectal cancer NUAK2 upregulation enhances cell migration and invasion through actin cytoskeleton remodeling. COSMIC; PMID: 27626308
Pancreatic cancer NUAK2 silencing reduces tumor growth and metastasis in preclinical models. COSMIC; PMID: 30356099

Expression Profile

Tissue Expression
Tissue nTPM level
Liver 12.3 Medium
Breast 8.7 Medium
Colon 10.1 Medium
Pancreas 6.5 Low
Lung 9.4 Medium
Kidney 7.2 Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 15.6 Hepatocellular carcinoma cell line
MCF7 11.2 Breast cancer cell line
HCT116 13.8 Colorectal carcinoma cell line
PANC-1 9.5 Pancreatic cancer cell line
A549 10.3 Lung carcinoma cell line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1015C>T (p.Arg339Trp) Missense <0.1% Unknown functional impact; reported in COSMIC
c.1342G>A (p.Glu448Lys) Missense <0.1% Unknown functional impact; reported in COSMIC
c.1660C>T (p.Arg554*) Nonsense <0.1% Predicted loss of function; truncating mutation
c.1885_1886insA (p.Leu629fs) Frameshift <0.1% Predicted loss of function; frameshift insertion
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., p.Arg554*, p.Leu629fs) are predicted to result in truncated or non-functional NUAK2 protein, leading to loss of kinase activity.

Gain of Function (GOF)

Amplification and overexpression of NUAK2 in cancers suggest a gain-of-function role, though specific activating point mutations are not well characterized.

Dominant Negative (DN)

No dominant-negative mutations have been reported for NUAK2.

Pathways

Hippo signaling pathway (Reactome: R-HSA-2028269)
AMPK signaling (KEGG: hsa04152)
Signaling by Receptor Tyrosine Kinases (Reactome: R-HSA-9006934)

Protein Summary

NUAK2 is a 628-amino acid serine/threonine kinase with an N-terminal kinase domain. It is activated by phosphorylation and functions downstream of LKB1 and AMPK. NUAK2 regulates cell polarity, migration, and survival by phosphorylating substrates such as MYPT1 and regulating YAP/TAZ activity. Its overexpression in multiple cancers highlights its role as a potential therapeutic target.

Related Products

Product name Cat.No. Species Gene ID
NUAK2 Knockout HEK293 Cell Line EDJ-KQ3323 Human 81788 Details Get a Quote
NUAK2 Knockout A-549 Cell Line EDJ-KQ24931 Human 81788 Details Get a Quote
NUAK2 Knockout HCT 116 Cell Line EDJ-KQ24932 Human 81788 Details Get a Quote
NUAK2 Knockout HeLa Cell Line EDJ-KQ24933 Human 81788 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: